INTRATECT 1g in 10 mL human normal immunoglobulin solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

intratect 1g in 10 ml human normal immunoglobulin solution for intravenous infusion vial

link medical products pty ltd t/a link pharmaceuticals - normal immunoglobulin, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: dilute hydrochloric acid; sodium hydroxide; glycine; water for injections - replacement therapy in. * primary immunodeficiency diseases. * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation. * idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * guillain barre syndrome. * kawasaki disease.

CSL TAIWAN Intragam P Normal Immunoglobulin (Human) 6% (60 g/L) 200 mL Australia - English - Department of Health (Therapeutic Goods Administration)

csl taiwan intragam p normal immunoglobulin (human) 6% (60 g/l) 200 ml

csl behring australia pty ltd - normal immunoglobulin, quantity: 12 g - injection, solution - excipient ingredients: maltose - intragam p is indicated for replacement igg therapy in: * primary immunodeficiency; * myeloma and chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; * congenital or acquired immune deficiency syndrome with recurrent infections. intragam p is indicated for immunomodulatory therapy in: * idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; * allogeneic bone marrow transplantation; * kawasaki disease.

CSL TAIWAN Intragam P Normal Immunoglobulin (Human) 6% (60 g/L) 50 mL Australia - English - Department of Health (Therapeutic Goods Administration)

csl taiwan intragam p normal immunoglobulin (human) 6% (60 g/l) 50 ml

csl behring australia pty ltd - normal immunoglobulin, quantity: 3 g - injection, solution - excipient ingredients: maltose - intragam p is indicated for replacement igg therapy in: * primary immunodeficiency; * myeloma and chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; * congenital or acquired immune deficiency syndrome with recurrent infections. intragam p is indicated for immunomodulatory therapy in: * idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; * allogeneic bone marrow transplantation; * kawasaki disease.

INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

intratect 5% 5g in 100ml human normal immunoglobulin solution for intravenous infusion vial

link medical products pty ltd t/a link pharmaceuticals - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; glycine; water for injections; dilute hydrochloric acid - replacement therapy in. * primary immunodeficiency diseases. * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation. * idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * guillain barre syndrome. * kawasaki disease.

INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

intratect 5% 1g in 20 ml human normal immunoglobulin solution for intravenous infusion vial

link medical products pty ltd t/a link pharmaceuticals - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: dilute hydrochloric acid; sodium hydroxide; glycine; water for injections - replacement therapy in. * primary immunodeficiency diseases. * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation. * idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * guillain barre syndrome. * kawasaki disease.

INTRATECT 5% 10g in 200 mL human normal immunoglobulin solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

intratect 5% 10g in 200 ml human normal immunoglobulin solution for intravenous infusion vial

link medical products pty ltd t/a link pharmaceuticals - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: glycine; sodium hydroxide; water for injections; dilute hydrochloric acid - replacement therapy in. * primary immunodeficiency diseases. * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation. * idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * guillain barre syndrome. * kawasaki disease.

INTRATECT 5% 2.5g in 50mL human normal immunoglobulin solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

intratect 5% 2.5g in 50ml human normal immunoglobulin solution for intravenous infusion vial

link medical products pty ltd t/a link pharmaceuticals - normal immunoglobulin, quantity: 50 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; dilute hydrochloric acid; glycine - replacement therapy in. * primary immunodeficiency diseases. * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulation. * idiopathic thrombocytopenic purpura, in adults or children at high risk of bleeding or prior to surgery to correct the platelet count.. * guillain barre syndrome. * kawasaki disease.

CSL COSTA RICA Intragam P Normal Immunoglobulin (Human) 6% (6g/100mL), solution for intravenous infusion Australia - English - Department of Health (Therapeutic Goods Administration)

csl costa rica intragam p normal immunoglobulin (human) 6% (6g/100ml), solution for intravenous infusion

csl behring australia pty ltd - normal immunoglobulin, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: maltose - intragam p is indicated for replacement igg therapy in: * primary immunodeficiency; * myeloma and chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; * congenital or acquired immune deficiency syndrome with recurrent infections. intragam p is indicated for immunomodulatory therapy in: * idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; * allogeneic bone marrow transplantation; * kawasaki disease; * guillain-barre syndrome (gbs).

CSL COLOMBIA Intragam P Normal Immunoglobulin (Human) 6% (6g/100mL), solution for intravenous infusion Australia - English - Department of Health (Therapeutic Goods Administration)

csl colombia intragam p normal immunoglobulin (human) 6% (6g/100ml), solution for intravenous infusion

csl behring australia pty ltd - normal immunoglobulin, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: maltose - intragam p is indicated for replacement igg therapy in: - primary immunodeficiency; - myeloma and chronic lymphocytic leukaemia with severe secondary - hypogammaglobulinaemia and recurrent infections; - congenital or acquired immune deficiency syndrome with recurrent infections. intragam p is indicated for immunomodulatory therapy in: - idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; - allogeneic bone marrow transplantation; - kawasaki disease; - guillain-barr? syndrome (gbs).

CSL Singapore Intragam P normal immunoglobulin (human) 6% (60g/L) injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl singapore intragam p normal immunoglobulin (human) 6% (60g/l) injection vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 60 mg/ml - injection, solution - excipient ingredients: maltose - intragam p is indicated in replacement igg therapy in: . primary immunodeficiency; . myeloma and chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections; . congenital acquired immune deficiency syndrome with recurrent infections. intragam is also indicated for immunoomodulatory therapy in idiopathic thrombocytopenic purpura (itp), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count; allogenic bone marrow transplantation; kawasaki disease.